Torrent Pharmaceuticals Ltd Company History

The Company has launched all over the country an oral anti impotence drug `Androz' (sidenafil nitrate).

The Company has launched De Platt (clopidogrel) the drug of choice for treating heart attack and stroke.

Torrent Pharmaceuticals has launched leflunomide - a new generation rheumatoid arthritis drug, at a big discount to its innovator, multinational Aventis Pharma.

Torrent Pharma’s manufacturing facilities certified with ISO 14001:1996.

Torrent’s R&D Centre received ISO/IEC 17025:1999 for its facilities by National Accreditation Board for Testing and Calibration Laboratories (NABL).

Torrent Pharma sets up a wholly owned subsidiaries in Germany and Brazil.

Torrent Pharma launches 'Aripiprazole' new antiseptic drug under the Brand name

of Arip MT.

a) New API manufacturing plant for catering to regulated markets; (b) New formulations facilities at one or more locations for catering to regulated markets & meeting the anticipated growth in the domestic market. ii) Incorporate a wholly owned subsidiary in USA.

Torrent unveils COX 2 variants

IDMA Quality Excellence Award Gold Trophy for its formulations and API facilities.

Torrent Pharma launches Ecogat

Torrent Pharmaceuticals Ltd, in association with State Mental Health Authority, Health and family Welfare Department, launches 'Sanidhya - Torrent Medical Healthline' in Bhat near Gandhinagar in Gujarat

Torrent, the Indian pharmaceutical major, announced the launch of Rozucor - the New "Super Statin" in Karnataka.

Torrent Pharmaceuticals Limited (TPL) has signed a non-exclusive agreement with Dr. Reddy's Laboratories Limited (DRL) for licensing and supplying the formulation of one of Torrent's blockbuster drug 'Domstal O' in the Gastro Intestinal segment

Torrent Pharmaceuticals Ltd has launched Etoricoxib, the new generation anti-arthritic drug under the brand name Torcoxia

Launches Duloxetine, a new-age anti-depressant under the brand name `Symbal'.

Torrent Pharmaceuticals Ltd launches a new anti-epileptic drug Levetiracetam

Torrent acquires Pfizer generic subsidiary in Germany

Torrent Pharmaceuticals signs agreement with Novo Nordisk, Denmark to establish new, dedicated formulation and packaging facility for Insulin, exclusively for Novo Nordisk

Torrent Pharma Receives USFDA Approval

Torrent’s Azuca launches 2 new blockbusters, Pregeb and Piopod

Entered into an in-licensing deal with Tasly of China to market its Cardiotonic pill in India

Torrent Pharmaceuticals Ltd has announced that the Company has launched Nexpro Fast (Immediate Release Esomeprazole), a Proton Pump Inhibitor (PPI), for the first time in India to treat peptic ulcers and GERD (Gastro Esophageal Reflux Disease).

The API and formulations manufacturing facilities located at Indrad (Gujarat, India) got US FDA approval

Torrent Pharma launches AzuCa, its super-specialty Diabetes division

Torrent Pharmaceuticals has given the Bonus in the Ratio of 1:1

Company has splits its Face value of Shares from Rs 10 to Rs 5

Torrent unveils laxative in tablet form

Torrent Pharma launches CVpill, The world’s first ‘polypill’ in Cardiac care

Indians to get slimmer and fitter: Torrent Pharma launches Rimoslim; India’s first Rimonabant

Torrent Pharma launches Fibotab; India’s first bulk laxative in tablet form

Torrent’s New Insulin Facility to produce 26 million vials pa for Novo Nordisk

The Board has recommended a dividend of Rs. 6.00 per equity share having face value of Rs. 5/- each.

Torrent Pharma gets US FDA approval for alfuzosin hydrochloride extended release tablets.

Board have recommended a normal annual dividend of Rs. 6 per equity share of Rs. 5/- each and a special dividend of Rs. 2.00 per equity share of Rs. 5/ each fully paid up.

The Board has appointed Haigreve khaitan as Additional Director.

The Board has recommended a final dividend of Rs. 2.50 per equity share.

Torrent has acquired Indian Branded Formulations Business of Elder.

Torrent has recommended to issue bonus shares in the ratio of 1: 1 i.e. one equity bonus share for each fully paid up equity share.

Torrent enters into exclusive licensing agreement with Reliance Life Sciences for 3 biosimilars.

Drug maker Torrent Pharma on Monday got an exemption from price control for one of its newly developed fixed dose combination (FDC) products.

Torrent Pharmaceuticals has completed acquision of Zyg Pharma Pvt Ltd.

Torrent Pharma has commenced commercial operations at its new plant in Dahej

Torrent Pharma launches Adalimumab biosimilar in India

Torrent Pharma's Dahej Plant receives EIR from US FDA

Torrent Pharma acquires Manufacturing Unit of Hyderabad based Glochem Industries Limited

Torrent Pharma acquires Brands from Novartis AG

"Torrent Pharma acquires Branded Formulation Business of India and Nepal of Unichem Laboratories Limited".

Torrent & Novo Nordisk India expand insulin manufacturing facility at Indrad.

Listed amongst top five 'Fastest Growing Companies (Middleweights Category)' by Business World Magazine.

Torrent Pharma acquires US-based Bio-Pharm Inc

Torrent Pharmac - Amendment to AOA/MOA

Torrent & Glenmark sign licensing agreement for co-marketing of Remogliflozin Etabonate in India

The Company has been informed that the name of Registrar & Share Transfer Agent (RTA) has been changed from KARVY FINTECH PRIVATE LIMITED to KFIN TECHNOLOGIES PRIVATE LIMITED with effect from 05th December, 2019.

Torrent Pharmac - USFDA Inspection At Torrent'S Manufacturing Facility At Levittown,

Torrent Pharma introduces MSD (a trade name of Merck & Co., Inc, Kenilworth, NJ, USA) and Ridgeback’s molnupiravir under the brand name Molnutor® in India

Torrent Pharma Enters Into Voluntary Licensing Agreement with Lilly to manufacture and distribute Baricitinib for Covid-19 in India

Torrent Pharma acquire 100% stake in Curatio Health Care (I) Private Limited.

Torrent Pharma has recommended the issue of Bonus Shares in the ratio of 1:1.

Torrent Pharmaceuticals gets EIR from US FDA for Dahej facility.

Torrent and Zydus sign licensing agreement for co-marketing Saroglitazar Mg, a critical treatment for chronic liver diseases in India.

Â